Corcept Therapeutics Inc
XMUN:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
XMUN:HTD
|
US |
|
A
|
AdCapital AG
DUS:ADC
|
DE |
|
C
|
China Citic Bank Corp Ltd
XMUN:D7C
|
CN |
|
C
|
Cipher Pharmaceuticals Inc
SWB:PHE
|
CA |
|
C
|
Cadiz Inc
F:2ZC
|
US |
|
S
|
SunCoke Energy Inc
SWB:S01
|
US |
|
A
|
Almaden Minerals Ltd
TSX:AMM
|
CA |
|
CHAPTERS Group AG
OTC:MDCKF
|
DE |
|
Newcap Holding A/S
F:25N0
|
DK |
|
H
|
Harper Hygienics SA
WSE:HRP
|
PL |
Wall St Price Targets
HTD Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
HTD is 78.57 EUR with a low forecast of 44.2 EUR and a high forecast of 124.07 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HTD's stock price target?
Price Target
78.57
EUR
According to Wall Street analysts, the average 1-year price target for
HTD is 78.57 EUR with a low forecast of 44.2 EUR and a high forecast of 124.07 EUR.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
65%
The compound annual growth rate for Operating Income over the next 8 years is 65%.
What is the Pre-Tax Income forecast for Corcept Therapeutics Inc?
Projected CAGR
108%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 108%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
46%
The compound annual growth rate for Net Income over the next 8 years is 46%.